心脏骤停后患者持续脑电图与常规脑电图的比较:CERTA随机对照试验分析
该分析基于CERTA试验(NCT03129438),纳入112例心脏骤停后昏迷成人,52例接受常规脑电图(每次20-30分钟,共两次),60例接受持续脑电图(30-48小时)。主要终点为6个月死亡率,次要终点为6个月脑功能分类(CPC)。单因素分析显示两组死亡率(常规脑电图59% vs 持续脑电图65%,p=0.318)和良好结局(CPC 1-2;常规脑电图33% vs 持续脑电图27%,p=0.247)无显著差异。多因素logistic回归校正可电击心律、自主循环恢复时间、血清神经元特异性烯醇化酶、脑电图背景反应性后,持续脑电图 vs 常规脑电图的死亡OR为1.60(95%CI 0.43-5.83,p=0.477),良好结局OR为0.51(95%CI 0.14-1.90,p=0.318)。作者认为,该发现不支持常规使用持续脑电图进行预后评估,有待大规模前瞻性随机试验验证。
要点
- 心脏骤停后昏迷患者中,持续脑电图(30-48小时)与两次常规脑电图(每次20-30分钟)相比,6个月死亡率无显著差异(常规脑电图59% vs 持续脑电图65%,p=0.318)。
- 6个月良好神经结局(CPC 1-2)在两组间也无显著差异(常规脑电图33% vs 持续脑电图27%,p=0.247)。
- 多因素校正可电击心律、自主循环恢复时间、血清神经元特异性烯醇化酶、脑电图背景反应性后,持续脑电图 vs 常规脑电图的死亡OR为1.60(95%CI 0.43-5.83,p=0.477),良好结局OR为0.51(95%CI 0.14-1.90,p=0.318)。
- 作者认为,该发现不支持常规使用持续脑电图进行心脏骤停后预后评估,有待大规模前瞻性随机试验验证。
适用人群与场景
- 心脏骤停后昏迷成人,纳入CERTA试验,接受持续脑电图(30-48小时)或两次常规脑电图(每次20-30分钟)监测。
研究设计与关键结果
- 该分析为CERTA随机对照试验(NCT03129438)的二次分析,纳入112例心脏骤停后昏迷成人,其中52例接受常规脑电图(每次20-30分钟,共两次),60例接受持续脑电图(30-48小时);女性31例(27.7%),死亡68例(60.7%)。
- 单因素分析:6个月死亡率常规脑电图59% vs 持续脑电图65%,p=0.318;良好结局(CPC 1-2)常规脑电图33% vs 持续脑电图27%,p=0.247。
- 多因素logistic回归校正可电击心律、自主循环恢复时间、血清神经元特异性烯醇化酶、脑电图背景反应性后:死亡(持续脑电图 vs 常规脑电图)OR 1.60,95%CI 0.43-5.83,p=0.477;良好结局OR 0.51,95%CI 0.14-1.90,p=0.318。
证据类型、等级与局限
- 证据类型:随机对照试验(CERTA)的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该分析提示持续脑电图或重复常规脑电图与心脏骤停后昏迷患者相当的结局相关,该发现不支持常规使用持续脑电图进行预后评估,有待大规模前瞻性随机试验验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Electroencephalography (EEG) is essential to assess prognosis in patients after cardiac arrest (CA). Use of continuous EEG (cEEG) is increasing in critically-ill patients, but it is more resource-consuming than routine EEG (rEEG). Observational studies did not show a major impact of cEEG versus rEEG on outcome, but randomized studies are lacking.
METHODS: We analyzed data of the CERTA trial (NCT03129438), including comatose adults after CA undergoing cEEG (30-48 hours) or two rEEG (20-30 minutes each). We explored correlations between recording EEG type and mortality (primary outcome), or Cerebral Performance Categories (CPC, secondary outcome), assessed blindly at 6 months, using uni- and multivariable analyses (adjusting for other prognostic variables showing some imbalance across groups).
RESULTS: We analyzed 112 adults (52 underwent rEEG, 60 cEEG,); 31 (27.7%) were women; 68 (60.7%) patients died. In univariate analysis, mortality (rEEG 59%, cEEG 65%, p = 0.318) and good outcome (CPC 1-2; rEEG 33%, cEEG 27%, p = 0.247) were comparable across EEG groups. This did not change after multiple logistic regressions, adjusting for shockable rhythm, time to return of spontaneous circulation, serum neuron-specific enolase, EEG background reactivity, regarding mortality (cEEG vs rEEG: OR 1.60, 95% CI 0.43-5.83, p = 0.477), and good outcome (OR 0.51, 95% CI 0.14-1.90, p = 0.318).
CONCLUSION: This analysis suggests that cEEG or repeated rEEG are related to comparable outcomes of comatose patients after CA. Pending a prospective, large randomized trial, this finding does not support the routine use of cEEG for prognostication in this setting.
TRIAL REGISTRATION: Continuous EEG Randomized Trial in Adults (CERTA); NCT03129438; July 25, 2019.
参考来源
- Urbano V, Alvarez V, Schindler K, et al. Continuous versus routine EEG in patients after cardiac arrest: Analysis of a randomized controlled trial (CERTA). Resuscitation. 2022. PMID: 35654226. doi:10.1016/j.resuscitation.2022.05.017
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。